Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 16.1B | 15.8B | 14.9B | 15.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 5.3B | 5.6B | 5.2B | 5.2B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.2B | 4.6B | 4.9B | 4.9B |
Tax provision | 1.4B | 1.0B | 1.3B | 1.4B |
Net income | 3.7B | 3.6B | 3.6B | 3.5B |
Basic EPS | — | 0.2 | 0.2 | 0.2 |
Diluted EPS | — | 0.2 | 0.2 | 0.2 |
Basic average shares | — | 14.4B | 14.4B | 14.2B |
Diluted average shares | — | 14.4B | 14.4B | 14.2B |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -339M | -298M | -339M | -270M |
Preferred stock dividends | — | — | — | — |